Literature DB >> 25877449

Cognitive and neuropsychiatric disease manifestations in MS.

A Feinstein1, J DeLuca2, B T Baune3, M Filippi4, H Lassman5.   

Abstract

Multiple sclerosis is associated with a wide array of behavioral problems. This brief overview begins with a summary of the pathophysiology and treatment of MS. Thereafter, sections are devoted to psychiatric syndromes and cognitive decline linked to MS. The immune basis and brain imaging data associated with these changes are subsequently reviewed. The frequency and severity of these changes in mentation highlight the point that MS patients should, as part of their routine care, have access to psychiatrists, neuropsychologists and allied mental health specialists.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cognition; Depression; MRI; Multiple sclerosis; Neuropathology; Neuropsychiatry

Year:  2012        PMID: 25877449     DOI: 10.1016/j.msard.2012.08.001

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  10 in total

1.  The Effect of Type D Personality on Quality of Life in Patients with Multiple Sclerosis.

Authors:  Seden Demirci; Kadir Demirci; Serpil Demirci
Journal:  Noro Psikiyatr Ars       Date:  2016-09-01       Impact factor: 1.339

2.  Utility of the INECO frontal screening (IFS) in the detection of executive dysfunction in patients with relapsing-remitting multiple sclerosis (RRMS).

Authors:  D Bruno; T Torralva; V Marenco; J Torres Ardilla; S Baez; E Gleichgerrcht; V Sinay; M Roca
Journal:  Neurol Sci       Date:  2015-06-26       Impact factor: 3.307

Review 3.  Measurement and maintenance of reserve in multiple sclerosis.

Authors:  Brian M Sandroff; Carolyn E Schwartz; John DeLuca
Journal:  J Neurol       Date:  2016-04-12       Impact factor: 4.849

4.  Validity and Reliability of the Turkish Version of the Multiple Sclerosis-Related Symptom Checklist.

Authors:  Zeliha Tülek; Cansu Polat; Murat Kürtüncü; Mefkure Eraksoy
Journal:  Noro Psikiyatr Ars       Date:  2016-04-26       Impact factor: 1.339

Review 5.  Effects of Menopause in Women With Multiple Sclerosis: An Evidence-Based Review.

Authors:  Riley Bove; Annette Okai; Maria Houtchens; Birte Elias-Hamp; Alessandra Lugaresi; Kerstin Hellwig; Eva Kubala Havrdová
Journal:  Front Neurol       Date:  2021-03-19       Impact factor: 4.003

6.  Mild myelin disruption elicits early alteration in behavior and proliferation in the subventricular zone.

Authors:  Elizabeth A Gould; Nicolas Busquet; Douglas Shepherd; Robert M Dietz; Paco S Herson; Fabio M Simoes de Souza; Anan Li; Nicholas M George; Diego Restrepo; Wendy B Macklin
Journal:  Elife       Date:  2018-02-13       Impact factor: 8.140

7.  Functional Magnetic Resonance Imaging Correlations Between Fatigue and Cognitive Performance in Patients With Relapsing Remitting Multiple Sclerosis.

Authors:  Dessislava Iancheva; Anastasya Trenova; Stefka Mantarova; Kiril Terziyski
Journal:  Front Psychiatry       Date:  2019-10-29       Impact factor: 4.157

8.  Kinetics of myelin breakdown products: A labeling study in patients with progressive multiple sclerosis.

Authors:  Kawita M S Kanhai; Sebastiaan C Goulooze; Jeroen van der Grond; Amy C Harms; Thomas Hankemeier; Ajay Verma; Gersham Dent; Juan Chavez; Henri Meijering; Geert Jan Groeneveld
Journal:  Clin Transl Sci       Date:  2021-11-19       Impact factor: 4.689

Review 9.  Sexual dysfunctions in MS in relation to neuropsychiatric aspects and its psychological treatment: A scoping review.

Authors:  Jana Pöttgen; Anita Rose; Wim van de Vis; Jannie Engelbrecht; Michelle Pirard; Stefanie Lau; Christoph Heesen; Sascha Köpke
Journal:  PLoS One       Date:  2018-02-27       Impact factor: 3.240

10.  The Effectiveness of Mindfulness-Based Stress Reduction on Psychological Distress and Cognitive Functioning in Patients with Multiple Sclerosis: a Pilot Study.

Authors:  Roos J Blankespoor; Melanie P J Schellekens; Sandra H Vos; Anne E M Speckens; Brigit A de Jong
Journal:  Mindfulness (N Y)       Date:  2017-03-28
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.